METABOLIC SYNDROME AND ARDS IN COVID-19

ABSTRACT

B Conclusions: b MetS, diagnosed by the clustering of obesity, prediabetes/DM, HTN, and dyslipidemia, is associated with significantly increased mortality and ARDS in a global population of hospitalized COVID-19 patients. B Introduction/Hypothesis: b Little is known about metabolic syndrome (MetS) and ARDS in COVID-19. However, patients from non-US hospitals had significantly higher hospital mortality as compared with US hospitals (24.5% vs 15.7%, aOR 1.58 [CI 1.41-1.77]) with similar findings noted when patients were stratified by MetS (34.1% vs 21.3%, aOR 1.49 [CI 1.08-2.06]). [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)